| Treatment of Moderate to Severe Plaque Psoriasis (NCT06542614) | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2024-08-27 |
| A Study of Camrelizumab Plus Apatinib as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Radical Resection or Ablation (NCT06546280) | Zhujiang Hospital | 2024-08-26 |
| GR1803 Injection in Patients With Relapsed/Refractory Multiple Myeloma (NCT06566547) | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 2024-08-26 |
| A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events (NCT06500884) | Janssen Research & Development, LLC | 2024-08-26 |
| A PhaseⅠ/Ⅱ Study of Simmitinib or Irinotecan Liposomes Combined With DP303c in Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma (NCT06577376) | Shanghai Runshi Pharmaceutical Technology Co., Ltd | 2024-08-26 |
| A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone) (NCT06564311) | Zenas BioPharma (USA), LLC | 2024-08-26 |
| High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer (NCT06538389) | City of Hope Medical Center | 2024-08-26 |
| A Study of Mevidalen (LY3154207) in Participants With Alzheimer's Disease (NCT06538116) | Eli Lilly and Company | 2024-08-26 |
| A Phase 2b Dose Finding Study of RMC-035 in Participants Undergoing Open-chest Cardiac Surgery (NCT06475274) | Guard Therapeutics AB | 2024-08-26 |
| Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy (NCT06449222) | BioNTech SE | 2024-08-26 |
| Imaging Techniques to Monitor Photosensitizer and sO2 Levels During Photodynamic Therapy of Actinic Keratoses (NCT05923060) | Case Comprehensive Cancer Center | 2024-08-25 |
| Oxygen Study-Orelabrutinib Combined With Obinutuzumab(O2) for First-Line Treatment of Marginal Zone Lymphoma (NCT06566807) | Huai'an First People's Hospital | 2024-08-25 |
| Peer Delivered HIV/Syphilis Self-Testing With Assisted Partner Notification Services (NCT06791928) | Makerere University | 2024-08-25 |
| Single Arm Clinical Trial (Gut Microbiota and HCC) (NCT06563947) | Xu Yong, MD | 2024-08-24 |
| HPV Vaccine, Imiquimod, and Metformin Combination Trial (NCT06686043) | Baylor College of Medicine | 2024-08-23 |
| Methotrexate, Tafasitamab, Lenalidomide and Rituximab in Patients With PCNSL (NCT05583071) | University of Cologne | 2024-08-23 |
| Efficacy of ICG-based NIR Imaging in Intralesional Curettage of Giant Cell Tumors of Bone in Limbs: a Prospective, Single-center, Single-arm, Open Study (NCT06647901) | Tang Xiaodong | 2024-08-23 |
| Communication Bridge 3 Study (NCT06191198) | University of Chicago | 2024-08-23 |
| SHR-A1811 Alone or in Combination With Adebrelimab as Neoadjuvant Treatment in HR Positive/HER2 Low Breast Cancer (NCT06340230) | Shengjing Hospital | 2024-08-23 |
| A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy (NCT06362369) | 7 Hills Pharma, LLC | 2024-08-23 |
| Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extrahepatic Cholangiocarcinoma (NCT06440993) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2024-08-23 |
| Oxaliplatin Combined With Irinotecan Liposome Injection II Through Hepatic Artery Infusion (HAIC) Followed by 5-FU/LV (HAIC) or Tegorgor Oral Combination Therapy for Hepatic Metastasis of Pancreatic Cancer (NCT06538623) | Ruijin Hospital | 2024-08-23 |
| Phase 2 Open Label Randomized Study of Pirtobrutinib and Brexucabtagene Autoleucel in R/R MCL (NCT06553872) | H. Lee Moffitt Cancer Center and Research Institute | 2024-08-23 |
| Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant (NCT05843253) | Nationwide Children's Hospital | 2024-08-22 |
| Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy (NCT06568042) | Eli Lilly and Company | 2024-08-22 |
| A Study of GC012F Injection in Subjects With Refractory Systemic Lupus Erythematosus (NCT06530849) | Gracell Biotechnologies (Shanghai) Co., Ltd. | 2024-08-22 |
| Study to Evaluate the Effect on Obesity of QW Nimacimab and QW Nimacimab Co-administered With Semaglutide vs Placebo (NCT06577090) | Skye Bioscience, Inc. | 2024-08-22 |
| TIL Gean Therapy Combined With Immunotherapy for Advanced or Metastatic Refractory Breast Cancer (NCT06532812) | Essen Biotech | 2024-08-22 |
| Letrozole and Misoprostol for Early Pregnancy Loss Management (NCT06452719) | University of Pennsylvania | 2024-08-22 |
| Long-term Safety Trial with NVDX3 (NCT06532253) | Novadip Biosciences | 2024-08-22 |
| Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors (NCT06535607) | AstraZeneca | 2024-08-22 |
| Neoadjuvant Chemotherapy With or Without GnRH Agonist for Premenopausal Triple-negative Early Breast Cancer Patients (NCT06225284) | National Taiwan University Hospital | 2024-08-22 |
| Empagliflozin for No-reflow Phenomenon in PCI for STEMI (NCT06342141) | Instituto Nacional de Cardiologia Ignacio Chavez | 2024-08-22 |
| The Safety and Efficacy of Terpene-enriched Cannabidiol (CBD) Oil in ADHD (NCT06542445) | Bazelet Nehushtan LtD. | 2024-08-22 |
| IMMUNOPLANT for Newly Diagnosed Multiple Myeloma (NCT06376526) | Dickran Kazandjian, MD | 2024-08-21 |
| Randomized Study of ABC-14 Regimen Compared With "3+7" Standard Induction Therapy or AB-14 for ND AML (NCT06451861) | Guangdong Provincial People's Hospital | 2024-08-21 |
| Study to Investigate Luveltamab Tazevibulin in Adults With Advanced or Metastatic Non-small Cell Lung Cancer (NCT06555263) | Sutro Biopharma, Inc. | 2024-08-21 |
| Assess Safety and Immunogenicity of A/H5 Inactivated Monovalent Influenza Vaccines at Different Antigen Dose Levels Adjuvanted With AS03 or MF59 (NCT06560151) | Biomedical Advanced Research and Development Authority | 2024-08-21 |
| Precision Treatment of HR+ HER2- Advanced Breast Cancer Based on SNF Molecular Subtyping (NCT06561022) | Fudan University | 2024-08-21 |
| Trial to Evaluate the Efficacy, Safety and Pharmacokinetics of RBD1016 in Participants With Chronic Hepatitis D (NCT06649266) | Ribocure Pharmaceuticals AB | 2024-08-21 |
| Microbiota Transplant Therapy for Children With Both Autism Spectrum Disorder and Gastrointestinal Disorders (NCT06503978) | Gut-Brain-Axis Therapeutics Inc. | 2024-08-20 |
| Study of Oral Weekly Lepetegravir (Formerly GS-1720) and Lenacapavir Pacfosacil (Formerly GS-4182) Versus Biktarvy in People With HIV-1 Who Are Virologically Suppressed (NCT06544733) | Gilead Sciences | 2024-08-20 |
| TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Lung Cancer (NCT06538012) | Essen Biotech | 2024-08-20 |
| A Study to Evaluate Safety and Efficacy of Empasiprubart in Adults With Dermatomyositis (NCT06284954) | argenx | 2024-08-20 |
| ProAgio in Combination With Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer (NCT06460298) | ProDa BioTech, LLC | 2024-08-20 |
| Phase Ⅱ Study of Adductor Canal Block With HR18034 for Postsurgical Pain Management in TKA (NCT06509958) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2024-08-20 |
| A Pilot Study to Examine the Effect of Egb761 on Plasma Biomarker Levels and on Cognitive Function in Patients With MCI (NCT07287852) | Hadassah Medical Organization | 2024-08-20 |
| Prophylactic Mesalamine to Prevent Colitis Following Treatment With Ipilimumab/Nivolumab (Ipi/Nivo) (NCT05663775) | AHS Cancer Control Alberta | 2024-08-20 |
| The Value of Using Colostrum Supplements on the Physical Performance and Cognitive Function in Healthy Subjects and Type 2 Diabetes (NCT06549556) | Al-Rasheed University College | 2024-08-20 |
| A Study of Different Sequences of Cilta-cel, Talquetamab in Combination With Daratumumab and Teclistamab in Combination With Daratumumab Following Induction With Daratumumab, Bortezomib, Lenalidomide and Dexamethasone in Participants With Standard-risk Newly Diagnosed Multiple Myeloma (NCT06577025) | Janssen Research & Development, LLC | 2024-08-20 |
| Tislelizumab Combined with Nab-Paclitaxel for First-Line Treatment of Advanced Triple-Negative Breast Cancer with Bone Metastasis，an Exploratory, Single-Arm, Multicenter Phase II Clinical Study (NCT06538896) | Zhejiang Cancer Hospital | 2024-08-20 |
| Chidamide Plus R-CHOP in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma With Other Molecular Subtypes (NCT06891157) | The First Affiliated Hospital with Nanjing Medical University | 2024-08-20 |
| COLDFIRE-III Trial: Efficacy of Irreversible Electroporation and Stereotactic Body Radiotherapy for Perivascular and Peribiliary Colorectal Liver Metastases (NCT06185556) | Amsterdam UMC, location VUmc | 2024-08-20 |
| CEB-01 in Locally Resectable Pancreatic Cancer (NCT06538857) | CEBIOTEX | 2024-08-20 |
| Safety and Efficacy of Pramipexole Treatment in Resistant Obsessive-Compulsive Disorder (OCD) (NCT06611592) | Clinical Academic Center (2CA-Braga) | 2024-08-20 |
| ADSCs Therapy in Patients With CTD-ILD (NCT06574581) | China Medical University Hospital | 2024-08-20 |
| Effect Of Abdominal Hypopressive Training On Stress Urinary Incontinence (NCT06599190) | Badr University | 2024-08-20 |
| Belantamab Mafodotin and Lenalidomide for the Treatment of Multiple Myeloma in Patients With Minimal Residual Disease Positive After Stem Cell Transplant (NCT04876248) | Roswell Park Cancer Institute | 2024-08-19 |
| Study of ATI-2138 in Adult Participants With Moderate to Severe Atopic Dermatitis (NCT06585202) | Aclaris Therapeutics, Inc. | 2024-08-19 |
| PMT for MDRO Decolonization (NCT05632315) | University of Pennsylvania | 2024-08-19 |
| A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission (NCT05719441) | National Institute of Allergy and Infectious Diseases (NIAID) | 2024-08-19 |
| Study to Assess the Safety, Tolerability, and Preliminary Efficacy of ST266 in Infants With Necrotizing Enterocolitis (NEC) (NCT06315738) | Noveome Biotherapeutics, formerly Stemnion | 2024-08-19 |
| Phase II/III Clinical Trial of Recombinant Human Serum Albumin in Cirrhotic Patients With Ascites (NCT06553456) | Protgen Ltd | 2024-08-19 |
| EC-104 Intravitreal Implant for the Treatment of Diabetic Macular Edema (NCT06536491) | Eclipse Life Sciences, Inc. | 2024-08-19 |
| Psilocybin Therapy for Depression in Parkinson's Disease (NCT06455293) | Joshua Woolley, MD, PhD | 2024-08-19 |
| Efficacy and Safety of Acyclovir-penciclovir Cream Versus an Abreva in the Suppression of Herpes Simplex Virus Eruptions (NCT06558838) | University of Utah | 2024-08-19 |
| A Study of IBI3004 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors (NCT06198426) | Innovent Biologics (Suzhou) Co. Ltd. | 2024-08-19 |
| Assessment of Efficacy and Safety of PD-1 Monoclonal Antibody Combined With IL-2 and CapeOX in Neoadjuvant Therapy for Locally Advanced Rectal Cancer Prior to Surgery: A Prospective, Multi-center, Randomized Controlled Study (NCT06884670) | The First Affiliated Hospital with Nanjing Medical University | 2024-08-18 |
| Empagliflozin Reversal of Arterial StiffnEss in Aging (NCT06506422) | University of Missouri-Columbia | 2024-08-18 |
| Ultrasonic Neuromodulation for Treatment of Cognitive Impairment (NCT06135051) | University of Utah | 2024-08-18 |
| Modified FOLFOXIRI Plus Target Therapy as a First Line Treatment for Advanced Colorectal Cancer a Prospective Phase Two Study (NCT06575127) | Al-Azhar University | 2024-08-17 |
| Immunogenicity and Tolerability of Booster Typhoid Conjugate Vaccine (TCV) 5-6 Years After Initial Dose in Children in Burkina Faso (NCT07624175) | Kathleen Neuzil | 2024-08-17 |
| Evaluate the Efficacy and Safety of Xianglei Tangzu Gao for the Treatment of Wagner Grade II Diabetic Foot Ulcers (NCT06531512) | Oneness Biotech Co., Ltd. | 2024-08-16 |
| Evaluating Cannabidiol as a Novel Anticraving Medication for Alcohol Use Disorder (NCT06512389) | Centre for Addiction and Mental Health | 2024-08-16 |
| A Trial of Polatuzumab Vedotin, Obinutuzumab and Glofitamab As a Peri-CAR-T Cell Treatment Strategy in Large B-cell Lymphoma (NCT06071871) | University College, London | 2024-08-16 |
| Safety and Efficacy of Fruquintinib Plus Chidamide and Sintilimab in the Third and Later Line Treatment of MSS/pMMR Metastatic Colorectal Cancer (NCT06685276) | Dai, Guanghai | 2024-08-16 |
| A Study of Enicepatide (CT-388) in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity (NCT06525935) | Carmot Therapeutics, Inc. | 2024-08-16 |
| A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies (NCT05589896) | Ossium Health, Inc. | 2024-08-16 |
| A Phase IIb Study of Glycopyrrolate Inhalation Solution Over 1 Week in Subjects With COPD (NCT06545500) | Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA | 2024-08-16 |
| Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01) (NCT06395103) | Merck Sharp & Dohme LLC | 2024-08-16 |
| A Study of Intravesical FL115 Alone or in Combination With BCG in Non-Muscle Invasive Bladder Cancer (NCT07122414) | Suzhou Forlong Biotechnology Co., Ltd | 2024-08-16 |
| Comparing Efficacy & Safety Of TNX-1300 To Placebo With UC For Treatment Of Acute Cocaine Intoxication In ED Subjects (CATALYST) (NCT06045793) | Tonix Pharmaceuticals, Inc. | 2024-08-16 |
| A Modular Phase 1/2 Study With CT7439 in Participants With Solid Malignancies (NCT06600789) | Carrick Therapeutics Limited | 2024-08-16 |
| Study of Avelumab and Tuvusertib in Participants With Advanced Urothelial Cancer That Has Progressed on Prior Anti-PD-(L)1 Therapy (JAVELIN DDRiver Bladder) (NCT06424717) | EMD Serono Research & Development Institute, Inc. | 2024-08-16 |
| Blinatumomab Plus Venetoclax Sequenced With Inotuzumab Ozogamicin in Treating B-ALL (NCT06554626) | First Affiliated Hospital of Zhejiang University | 2024-08-15 |
| Bone in CKD Alkali Response (BICARb Pilot Trial) (NCT05918029) | Albert Einstein College of Medicine | 2024-08-15 |
| Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent (NCT06322342) | Reveal Pharmaceuticals Inc. | 2024-08-15 |
| Measuring Psychomotor Response to L-DOPA Challenge As a Biomarker for Outcomes in Late-Life Depression: a Pilot Feasibility Trial (NCT06626152) | University of British Columbia | 2024-08-15 |
| Phase Ⅱ Clinical Study of Surufatinib Combined With Gemcitabine and Cisplatin Plus Durvalumab/Pembrolizumab Regimen in the Treatment of Advanced Biliary Tract Cancer (NCT06708858) | Dai, Guanghai | 2024-08-15 |
| Neoadjuvant Radiochemotherapy Combined With Cadonilizumab for Local Advanced Esophageal Squamous Cell Cancer (NCT07016724) | The First Affiliated Hospital of Zhengzhou University | 2024-08-15 |
| A Study on the Efficacy of Disitamab Vedotin in Advanced HER2-positive Paget's Disease. (NCT06561555) | Fudan University | 2024-08-15 |
| To Evaluate IAH0968 in Combination With CAPEOX in HER2-positive Gastric Cancer (NCT06504732) | SUNHO（China）BioPharmaceutical CO., Ltd. | 2024-08-15 |
| Assessing the Clinical Outcomes of Dapagliflozin Versus Acetazolamide in Patients With Acute Heart Failure (NCT06783166) | Mansoura University | 2024-08-15 |
| Phase II Study of FCN-159 in NF2 Nerve Sheath Tumors (NCT06553365) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2024-08-15 |
| A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease (NCT06540833) | Intra-Cellular Therapies, Inc. | 2024-08-15 |
| CD19-targeted CAR T Cells for Relapsed or Refractory (R/R) Large B-cell Lymphoma (NCT06479356) | Shanghai Ming Ju Biotechnology Co., Ltd. | 2024-08-15 |
| Evaluate Efficacy of Devimistat in Combination With mFFX in 2nd Line Patients With Metastatic Pancreatic Cancer (NCT06518538) | Cornerstone Pharmaceuticals | 2024-08-15 |
| Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy (NCT06268665) | University of California, Davis | 2024-08-15 |
| A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease (NCT06546670) | Novartis Pharmaceuticals | 2024-08-15 |
| Perinatal Depression & Anxiety (PDA) and Maternal Gut Microbiome (NCT06074250) | The Canadian College of Naturopathic Medicine | 2024-08-15 |